T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$1.3B |
| 2 |
American Airlines Group
AAL
|
+$853M |
| 3 |
Intuitive Surgical
ISRG
|
+$816M |
| 4 |
Morgan Stanley
MS
|
+$681M |
| 5 |
Wynn Resorts
WYNN
|
+$622M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$1.4B |
| 2 |
eBay
EBAY
|
+$763M |
| 3 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$760M |
| 4 |
Broadcom
AVGO
|
+$757M |
| 5 |
US Bancorp
USB
|
+$686M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.64% |
| 2 | Consumer Discretionary | 13.46% |
| 3 | Financials | 12.79% |
| 4 | Industrials | 12.13% |
| 5 | Technology | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ATML
301
DELISTED
ATMEL CORP
ATML
| $366M | 0.08% |
39,019,320
+49,620
| +0.1% | +$415K |
|
302
Western Union
WU
$2.2B
| $365M | 0.08% |
21,027,529
+6,425,796
| +44% | +$104M |
|
|
DD
303
DELISTED
Du Pont De Nemours E I
DD
| $365M | 0.08% |
5,865,838
+38,785
| +0.7% | +$2.49M |
|
304
Accenture
ACN
$110B
| $364M | 0.08% |
4,504,704
-64,080
| -1% | -$5.14M |
|
305
SBA Communications
SBAC
$19.3B
| $361M | 0.08% |
3,527,801
-2,116,983
| -38% | -$203M |
|
306
MSCI
MSCI
$40.8B
| $361M | 0.08% |
7,866,568
-457,900
| -6% | -$19.7M |
|
307
Eaton
ETN
$178B
| $360M | 0.08% |
4,667,775
+9,842
| +0.2% | +$730K |
|
308
SS&C Technologies
SSNC
$18.7B
| $359M | 0.08% |
16,252,556
+1,298,900
| +9% | +$26.9M |
|
309
Petrobras Class A
PBR.A
$103B
| $359M | 0.08% |
22,948,784
-2,849,700
| -11% | -$44M |
|
310
Public Storage
PSA
$60.7B
| $358M | 0.08% |
2,091,846
+79,468
| +4% | +$13.6M |
|
|
GGP
311
DELISTED
GGP Inc.
GGP
| $355M | 0.08% |
15,069,387
+722,070
| +5% | +$16.8M |
|
|
ARG
312
DELISTED
Airgas Inc
ARG
| $353M | 0.08% |
3,244,209
-34,399
| -1% | -$3.67M |
|
|
MINI
313
DELISTED
Mobile Mini Inc
MINI
| $352M | 0.08% |
7,348,406
+547,530
| +8% | +$24.3M |
|
314
Cboe Global Markets
CBOE
$29.5B
| $347M | 0.08% |
7,058,333
+380,700
| +6% | +$19.3M |
|
315
General Mills
GIS
$20.2B
| $336M | 0.07% |
6,397,933
-5,709,393
| -47% | -$304M |
|
316
Deere & Co
DE
$167B
| $335M | 0.07% |
3,699,391
+27,380
| +0.7% | +$2.52M |
|
317
Teleflex
TFX
$5.91B
| $333M | 0.07% |
3,149,940
+411,310
| +15% | +$43.1M |
|
318
Prologis
PLD
$133B
| $333M | 0.07% |
8,094,642
+334,515
| +4% | +$13.8M |
|
319
Tapestry
TPR
$32.4B
| $333M | 0.07% |
9,726,840
-2,991,039
| -24% | -$128M |
|
320
Valero Energy
VLO
$93.3B
| $332M | 0.07% |
6,628,027
-4,954,141
| -43% | -$273M |
|
321
Viavi Solutions
VIAV
$9.47B
| $330M | 0.07% |
46,468,472
-70,346
| -0.2% | -$478K |
|
|
RAX
322
DELISTED
Rackspace Hosting Inc
RAX
| $329M | 0.07% |
9,772,073
-26,932
| -0.3% | -$894K |
|
323
Xerox
XRX
$423M
| $327M | 0.07% |
9,973,762
+1,900,044
| +24% | +$60.4M |
|
324
Pediatrix Medical
MD
$2.12B
| $325M | 0.07% |
5,583,158
-8,133
| -0.1% | -$479K |
|
|
JOY
325
DELISTED
Joy Global Inc
JOY
| $321M | 0.07% |
5,208,089
+15,500
| +0.3% | +$932K |
|
Similar funds
T. Rowe Price Associates's Q2 2014 Portfolio in Review
As of Q2 2014, T. Rowe Price Associates held 2,596 positions worth $463B, up 3.9% from $445B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
T. Rowe Price Associates's Q2 2014 filing shows 97 new, 1,091 increased, 793 reduced and 67 closed positions. Its largest new stake was Teva Pharmaceuticals: 4,638,481 shares worth $243M. The largest sale was Procter & Gamble, an estimated $1.4B.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2014 buy was Teva Pharmaceuticals: 4,638,481 shares worth $243M.
- T. Rowe Price Associates added most to Allergan Inc in Q2 2014, an estimated $1.3B increase.
- T. Rowe Price Associates's biggest Q2 2014 reduction was Procter & Gamble, cutting an estimated $1.4B.
- T. Rowe Price Associates fully exited Santander in Q2 2014, selling an estimated $134M.
- T. Rowe Price Associates's ten largest holdings make up 12% of its $463B portfolio in Q2 2014.
- T. Rowe Price Associates opened 97 new positions and closed 67 in Q2 2014.
- T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $463B.
Based on T. Rowe Price Associates's 13F filing for Q2 2014, filed 14 Aug 2014.